What companies are MANE's competitors?

Veradermics, Incorporated (MANE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does MANE compare to its peers?

The peer comparison table on this page shows Veradermics, Incorporated (MANE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does MANE operate in?

Veradermics, Incorporated (MANE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

MANE (Veradermics, Incorporated) is a recent IPO.

It began trading on February 4, 2026, giving it under six months of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.

MANE

Veradermics, Incorporated

NYSE·Biotechnology · Healthcare

$109.49$3.45+3.25%

After hours·$106.82−2.44%

Market cap$4.57B·Market closed·Jul 21 8:00 PM UTC

Frequently Asked Questions About MANE

What companies are MANE's competitors?: Veradermics, Incorporated (MANE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does MANE compare to its peers?: The peer comparison table on this page shows Veradermics, Incorporated (MANE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does MANE operate in?: Veradermics, Incorporated (MANE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

MANE (Veradermics, Incorporated) is a recent IPO.

MANE

Veradermics, Incorporated

NYSE·Biotechnology · Healthcare

$109.49$3.45+3.25%

After hours·$106.82−2.44%

Market cap$4.57B·Market closed·Jul 21 8:00 PM UTC

Peers


TVTX	Travere Therapeutics, Inc.	$56.58	$5.3B
HELP	Cybin Inc. Common Stock	$8.10	$405.3M
ABEO	Abeona Therapeutics Inc.	$6.53	$372.2M
OVID	Ovid Therapeutics Inc.	$2.41	$317.8M
THAR	Tharimmune, Inc.	$3.54	$139.9M
PLYX	Polaryx Therapeutics, Inc. Common Stock	$2.32	$115.6M
LSTA	Lisata Therapeutics, Inc.	$2.24	$20.4M
XTLB	XTL Biopharmaceuticals Ltd.	$2.92	$6.9M
ADIL	Adial Pharmaceuticals, Inc.	$2.74	$2.6M
DRMA	Dermata Therapeutics, Inc.	$1.28	$872.4K

Frequently Asked Questions About MANE

What companies are MANE's competitors?: Veradermics, Incorporated (MANE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does MANE compare to its peers?: The peer comparison table on this page shows Veradermics, Incorporated (MANE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does MANE operate in?: Veradermics, Incorporated (MANE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.